Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Opioid Risk Tool Pegs Addiction Likelihood at Less Than 0.2% for Low-Risk Chronic-Pain Patients

By ACEP Now | on April 11, 2014 | 0 Comment
Break Room
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

With no perfect way to assess risk, an objective tool combined with urine drug testing can help emergency physicians assess risk of dependence on long-term opioid use in patients with no history of addiction

You Might Also Like
  • ACEP’s New Pain Management Section Provides Venue to Discuss Pain Topics, Opioid Addiction
  • Safe Discharge in Non-Low Risk Chest Pain Patients
  • The Role of Emergency Physicians in Caring for Patients with Chronic Pain
Explore This Issue
ACEP Now: Vol 33 – No 04 – April 2014

“In chronic-pain patients who have been properly screened for addiction risk using the Opioid Risk Tool (see Table 1), the risk of addiction for those who are scored at low risk is less than 0.2 percent”

That 0.2 percent is a great stat! Does anyone know where exactly it comes from?

In response to the great question from Alyssa Berns, here are my comments.

The data on risk have been accumulated in our nine community-based chronic non-cancer pain clinics over a period of three years. In our clinics, we average 60,000 visits per year, representing approximately 8,000 patients. All patients fill out the Opioid Risk Tool (ORT), along with many other validated assessment forms, at the time of entry into the clinics. Patients also sign an opioid agreement and are required to undergo random urine drug screening at a frequency determined by that initial risk stratification (anywhere from two per year to monthly).

Our patient retention is high, so we have fairly consistent evidence with respect to compliance and substance misuse. Others, however, have not reported such consistency in the value of any screening tool they have used. Witkin et al (J Opioid Manag. 2013;9:177-187) found that 38 percent of their low-risk patients had aberrant drug-related behavior (ADRB). It is important to note that ADRB is not the equivalent of addiction and represents acting-out behavior seen both with oligoanalgesia and addiction.

The Canadian Opioid Guideline (cited in the article) recommends the use of the ORT to establish baseline risk; it is the preferred screening tool at present. Another tool, the Drug Abuse Screening Test (DAST-20), specifically looks at presence of addiction risk at the point in time of seeing the patient rather than predicting risk in the future, as the ORT is meant to do. In Gorchynski et al (Cal J Emerg Med. 2005;6:3-8), the DAST-20 identified 50 percent of the patients with addiction who would not have been identified by the clinician. This tool may be another one to consider.

We, as clinicians, cannot judge in a few minutes why the patient is manifesting ADRB…To help us better judge, validated tools and objective testing should be to what we turn.

A caveat: as per Brown et al (J Opioid Manag. 2011;7:467-483), the majority of patients seen in a family practice do not fall into the low-risk category; I would assume that would be equally true in the ED. Assessment of risk is to establish a level of comfort, along with the subjective (and biased) assessment of the caregiver; the latter has been shown to be fraught with error. Urine drug testing can also be of value: no one already testing positive for cocaine, for example, should be leaving any ED with a prescription for any controlled substance. The other important objective resource is the state-based drug-monitoring programs that allow us to see who has received what prescriptions.

Pages: 1 2 | Single Page

Topics: AddictionDrug ScreeningEmergency MedicineEmergency PhysicianLab TestOpioidOpioid CrisisPsychology and Behavioral DisorderRisk

Related

  • EM Runs in the Family

    February 26, 2025 - 0 Comment
  • How to Manage Elderly Patient Pain without Opioids

    February 13, 2024 - 0 Comment
  • Are Opiates Futile in Low Back Pain?

    October 15, 2023 - 0 Comment

Current Issue

ACEP Now: June 2025 (Digital)

Read More

About the Author

ACEP Now

View this author's posts »

No Responses to “Opioid Risk Tool Pegs Addiction Likelihood at Less Than 0.2% for Low-Risk Chronic-Pain Patients”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603